Glassman Wealth Services’s Evolent Health EVH Stock Holding History

Glassman Wealth Services’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30	Closed	-$991	–	733
2023 Q4	$991	Hold	30	–	–	﹤0.01%	1544
2023 Q3	$817	Hold	30	–	–	﹤0.01%	1612
2023 Q2	$909	Hold	30	–	–	﹤0.01%	1470
2023 Q1	$974	Hold	30	–	–	﹤0.01%	1442
2022 Q4	$842	Buy	30 +8	+36%	+$229	﹤0.01%	1474
2022 Q3	$1K	Sell	22 -5	-19%	-$176	﹤0.01%	1389
2022 Q2	$1K	Hold	27	–	–	﹤0.01%	1398
2022 Q1	$1K	Buy	+27	New	+$707	﹤0.01%	1383
2019 Q4	–	Sell	-31	Closed	–	–	1260
2019 Q3	$0	Buy	+31	New	+$222	﹤0.01%	1133
2019 Q2	–	Sell	-18	Closed	–	–	1157
2019 Q1	$0	Buy	+18	New	+$285	﹤0.01%	1081

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Glassman Wealth Services's EVH Position: Q1 2024 in Review

Glassman Wealth Services sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 30 shares — an estimated $991 sold.

Glassman Wealth Services first reported a position in EVH in Q1 2019 and held it in 10 quarters. The position peaked at $1K in Q3 2022. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

Glassman Wealth Services reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 30 Evolent Health shares in Q1 2024, an estimated $991.
Glassman Wealth Services first reported a position in Evolent Health in Q1 2019 and held it in 10 quarters.
Glassman Wealth Services's Evolent Health position peaked at $1K in Q3 2022.
251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.